Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
$ in Millions
Total
Class A Common Stock
Class B Common Stock
Ordinary Shares
A Ordinary Shares
Ordinary Shares
B Ordinary Shares
Additional Paid-In Capital
Receivable from Employees for purchase of Common Stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2020       1,483,795 5,353,970          
Beginning balance at Dec. 31, 2020 $ (733.4)       $ 0.1 $ 9.6 $ (2.4) $ (793.4) $ 50.5 $ 2.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation expense (0.1)         (0.1)        
Receivable from employees (0.1)           (0.1)      
Net loss (40.7)             (40.7)    
Other comprehensive loss (17.9)               (17.9)  
Ending balance (in shares) at Mar. 31, 2021       1,483,795 5,353,970          
Ending balance at Mar. 31, 2021 (792.2)       $ 0.1 9.5 (2.5) (834.1) 32.6 2.2
Beginning balance (in shares) at Dec. 31, 2020       1,483,795 5,353,970          
Beginning balance at Dec. 31, 2020 (733.4)       $ 0.1 9.6 (2.4) (793.4) 50.5 2.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net loss (141.3)                  
Other comprehensive loss (21.7)                  
Ending balance (in shares) at Sep. 30, 2021       1,483,795 5,353,970          
Ending balance at Sep. 30, 2021 (899.0)       $ 0.1 9.5 (1.9) (937.6) 28.8 2.1
Beginning balance (in shares) at Mar. 31, 2021       1,483,795 5,353,970          
Beginning balance at Mar. 31, 2021 (792.2)       $ 0.1 9.5 (2.5) (834.1) 32.6 2.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Receivable from employees 0.1           0.1      
Net loss (54.0)             (53.9)   (0.1)
Other comprehensive loss 6.6               6.6  
Ending balance (in shares) at Jun. 30, 2021       1,483,795 5,353,970          
Ending balance at Jun. 30, 2021 (839.5)       $ 0.1 9.5 (2.4) (888.0) 39.2 2.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Impairment loss on lease adoption (2.9)             (2.9)    
Receivable from employees 0.5           0.5      
Net loss (46.7)             (46.7)   0.0
Other comprehensive loss (10.4)               (10.4)  
Ending balance (in shares) at Sep. 30, 2021       1,483,795 5,353,970          
Ending balance at Sep. 30, 2021 (899.0)       $ 0.1 9.5 $ (1.9) (937.6) 28.8 2.1
Beginning balance (in shares) at Dec. 31, 2021   199,523,292 8,560,540              
Beginning balance at Dec. 31, 2021 1,784.0         1,845.5   (131.6) (20.7) 90.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation expense 7.8         7.8        
Warrant exercises (in shares)   100                
Stock compensation to directors in lieu of cash compensation 0.1         0.1        
Net loss (19.0)             (17.7)   (1.3)
Other comprehensive loss (15.7)               (14.2) (1.5)
Ending balance (in shares) at Mar. 31, 2022   199,523,392 8,560,540              
Ending balance at Mar. 31, 2022 1,757.2         1,853.4   (149.3) (34.9) 88.0
Beginning balance (in shares) at Dec. 31, 2021   199,523,292 8,560,540              
Beginning balance at Dec. 31, 2021 1,784.0         1,845.5   (131.6) (20.7) 90.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation expense 8.3         8.3        
Net loss (128.7)                  
Other comprehensive loss (103.2)                  
Ending balance (in shares) at Sep. 30, 2022   200,102,086 8,040,540              
Ending balance at Sep. 30, 2022 1,575.0         1,875.4   (255.0) (119.0) 73.6
Beginning balance (in shares) at Mar. 31, 2022   199,523,392 8,560,540              
Beginning balance at Mar. 31, 2022 1,757.2         1,853.4   (149.3) (34.9) 88.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Stock issued for vested restricted stock units (in shares)   21,414                
Stock compensation to directors in lieu of cash compensation (in shares)   9,840                
Stock compensation to directors in lieu of cash compensation 0.1         0.1        
Conversion of shares of class B shares of common stock to class A (in shares)   500,000 (500,000)              
Conversion of shares of class B shares of common stock to class A 0.0         4.9       (4.9)
Purchase accounting adjustments to fair value of noncontrolling interests (1.9)                 (1.9)
Net loss (59.3)             (58.6)   (0.7)
Other comprehensive loss (45.6)               (43.8) (1.8)
Ending balance (in shares) at Jun. 30, 2022   200,054,646 8,060,540              
Ending balance at Jun. 30, 2022 1,658.9         1,866.8   (207.9) (78.7) 78.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation expense 8.4         8.4        
Stock issued for vested restricted stock units (in shares)   13,488                
Stock compensation to directors in lieu of cash compensation (in shares)   13,952                
Stock compensation to directors in lieu of cash compensation 0.1         0.1        
Conversion of shares of class B shares of common stock to class A (in shares)   20,000 (20,000)              
Conversion of shares of class B shares of common stock to class A 0.0         0.2       (0.2)
Net loss (50.4)             (47.1)   (3.3)
Other comprehensive loss (41.9)               (40.3) (1.6)
Ending balance (in shares) at Sep. 30, 2022   200,102,086 8,040,540              
Ending balance at Sep. 30, 2022 $ 1,575.0         $ 1,875.4   $ (255.0) $ (119.0) $ 73.6